Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    FromBusiness Of Biotech

    Start listeningView podcast show

    AI-Driven Biologics With Fountain Therapeutics' William Greene, M.D

    FromBusiness Of Biotech

    ratings:
    Length:
    50 minutes
    Released:
    Feb 28, 2022
    Format:
    Podcast episode

    Description

    With its hypothesis-free, target-free, AI-driven drug discovery platform, Fountain Therapeutics is turning the traditional drug discovery pathway on its ear to address a variety of age-related disease. On this week's episode of the Business of Biotech, Fountain CEO William Greene, M.D. joins us to discuss the approach, its rationale,  and how the company is applying substantial support from the likes of Eli Lilly, Alexandria Venture Investments, R42 Group,  Khosla Ventures, and Nan Fung Life Sciences.
    Released:
    Feb 28, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.